Regentis Biomaterials Ltd. funding
Regentis Biomaterials Ltd., a biotechnology company based in Herzliya, Israel, filed a Form D with the SEC on June 25, 2026 and reported $6.5M raised.
Amount raised$6.5M
Offering size$6.5M
Filed with the SECJune 25, 2026
First saleJune 17, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationHerzliya, Israel
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far22
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 25
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology